HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $362,135 | +0.1% | 3,521 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $361,908 | -56.4% | 3,316 | -54.6% | 0.00% | -75.0% |
| Q4 2022 | $830,512 | -4.1% | 7,298 | -47.9% | 0.00% | 0.0% |
| Q3 2022 | $866,000 | -35.0% | 13,999 | -16.2% | 0.00% | -33.3% |
| Q2 2022 | $1,332,000 | -33.2% | 16,704 | -11.9% | 0.01% | -14.3% |
| Q1 2022 | $1,994,000 | -12.1% | 18,957 | -10.0% | 0.01% | 0.0% |
| Q4 2021 | $2,269,000 | -13.7% | 21,056 | -12.3% | 0.01% | -22.2% |
| Q3 2021 | $2,630,000 | -0.9% | 24,010 | -15.3% | 0.01% | 0.0% |
| Q2 2021 | $2,653,000 | +3.1% | 28,331 | +1.3% | 0.01% | -10.0% |
| Q1 2021 | $2,573,000 | +16.4% | 27,958 | -7.5% | 0.01% | +25.0% |
| Q4 2020 | $2,211,000 | -6.7% | 30,221 | -1.0% | 0.01% | -20.0% |
| Q3 2020 | $2,371,000 | +18.0% | 30,525 | -15.5% | 0.01% | 0.0% |
| Q2 2020 | $2,009,000 | +64.8% | 36,142 | -12.2% | 0.01% | +25.0% |
| Q1 2020 | $1,219,000 | -29.1% | 41,164 | -13.3% | 0.01% | -11.1% |
| Q4 2019 | $1,719,000 | +442.3% | 47,475 | +307.2% | 0.01% | +350.0% |
| Q3 2019 | $317,000 | +1.9% | 11,658 | -9.9% | 0.00% | 0.0% |
| Q2 2019 | $311,000 | – | 12,933 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |